LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Technology A2 Biotherapeutics has developed proprietary Tmod(TM) technology and logic-gated cell therapies, positioning them at the forefront of precision immuno-oncology which offers opportunities to collaborate on cutting-edge therapeutic platforms.

Clinical Progress The company recently dosed the first patient in its EVEREST-2 Phase 1 clinical trial targeting mesothelin, indicating active clinical development that can benefit from partnerships or supply chain solutions.

Strong Funding A2 has secured significant financial backing with an $80M Series C and additional grants, demonstrating investor confidence and potential for growth support, making it a prime target for technology, manufacturing, or services expansion.

Market Positioning Focusing on next-generation cell therapies targeting solid tumors, A2 is positioned within a high-growth segment of biotechnology which presents opportunities for strategic alliances and market expansion efforts.

Research & Events The company's active participation in industry conferences and presentation of new research indicates ongoing innovation and visibility, providing opportunities for collaborative research, data sharing, or joint marketing initiatives.

Similar companies to A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc. Tech Stack

A2 Biotherapeutics, Inc. uses 8 technology products and services including Fastly, Amazon Simple Email Service, Google Fonts API, and more. Explore A2 Biotherapeutics, Inc.'s tech stack below.

  • Fastly
    Content Delivery Network
  • Amazon Simple Email Service
    Email
  • Google Fonts API
    Font Scripts
  • Font Awesome
    Font Scripts
  • TweenMax
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Magnific Popup
    Web Tools And Plugins

Media & News

A2 Biotherapeutics, Inc.'s Email Address Formats

A2 Biotherapeutics, Inc. uses at least 2 format(s):
A2 Biotherapeutics, Inc. Email FormatsExamplePercentage
FLast@a2bio.comJDoe@a2bio.com
47%
Last@a2bio.comDoe@a2bio.com
6%
FLast@a2bio.comJDoe@a2bio.com
47%
FLast@a2biotherapeutics.comJDoe@a2biotherapeutics.com
97%
FMiddleLast@a2biotherapeutics.comJMichaelDoe@a2biotherapeutics.com
2%
First@a2biotherapeutics.comJohn@a2biotherapeutics.com
1%

Frequently Asked Questions

Where is A2 Biotherapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s main headquarters is located at 30301 Agoura Road Suite 210 Calabasas, California 91301 United States. The company has employees across 1 continents, including North America.

What is A2 Biotherapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s official website is a2bio.com and has social profiles on LinkedInCrunchbase.

What is A2 Biotherapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does A2 Biotherapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of February 2026, A2 Biotherapeutics, Inc. has approximately 121 employees across 1 continents, including North America. Key team members include Chief Medical Officer: W. G. M.Co-Founder A2 Biotherapeutics: M. G.Vp, Head Of Human Resources: A. Y.. Explore A2 Biotherapeutics, Inc.'s employee directory with LeadIQ.

What industry does A2 Biotherapeutics, Inc. belong to?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc. operates in the Biotechnology Research industry.

What technology does A2 Biotherapeutics, Inc. use?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s tech stack includes FastlyAmazon Simple Email ServiceGoogle Fonts APIFont AwesomeTweenMaxModernizrYoast SEOMagnific Popup.

What is A2 Biotherapeutics, Inc.'s email format?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc.'s email format typically follows the pattern of FLast@a2bio.com. Find more A2 Biotherapeutics, Inc. email formats with LeadIQ.

How much funding has A2 Biotherapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of February 2026, A2 Biotherapeutics, Inc. has raised $300K in funding. The last funding round occurred on May 06, 2025 for $300K.

When was A2 Biotherapeutics, Inc. founded?

Minus sign iconPlus sign iconA2 Biotherapeutics, Inc. was founded in 2018.

A2 Biotherapeutics, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors.

A2 engineers T cells that target the loss of genetic material in tumors, enabling the selective killing of tumor cells while leaving normal cells unharmed.

The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and has raised $136M since inception. Our investors include The Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments (Office of the Chief Investment Officer of the Regents) and Hartford HealthCare Endowment.

Section iconCompany Overview

Headquarters
30301 Agoura Road Suite 210 Calabasas, California 91301 United States
Website
a2bio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $300K

    A2 Biotherapeutics, Inc. has raised a total of $300K of funding over 6 rounds. Their latest funding round was raised on May 06, 2025 in the amount of $300K.

  • $50M$100M

    A2 Biotherapeutics, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $300K

    A2 Biotherapeutics, Inc. has raised a total of $300K of funding over 6 rounds. Their latest funding round was raised on May 06, 2025 in the amount of $300K.

  • $50M$100M

    A2 Biotherapeutics, Inc.'s revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    W. G. M.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Co-Founder A2 Biotherapeutics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. Y.
    Vp, Head Of Human Resources
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. C.
    Senior Director, Head Of Supply Chain Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. V.
    Senior Director, Head Of Regulatory Affairs
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    J. J. S.
    Senior Director, Strategy & Business Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. L.
    Clinical Development Associate Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. L.
    Director, Quality
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. A.
    Associate Director, Accounting
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Q. Z.
    Senior Director, Process Development
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.